?

Log in

No account? Create an account
 
 
15 September 2010 @ 10:18 am
Pain Community News  
http://www.painfoundation.org/learn/publications/pcn/10fall/e-pub.html

Also of interest:

http://www.painfoundation.org/take-action/natl-efforts/rems/faq.html

excerpt:

Because of its role in regulating controlled substances, including ingredients in pain medication, the Drug Enforcement Agency (DEA) is also influential in shaping federal pain policy and regulations. Prescription drug abuse is a serious public health issue. FDA and DEA are involved with pain medication regulation to attempt to curb its misuse and abuse, while at the same time ensuring access to people who need it.

What are REMS?

REMS stands for Risk Evaluation Mitigation Strategies. One component of the 2007 Food and Drug Administration Amendments Act (FDAAA) expanded FDA’s authority to regulate drugs after they are approved. As a part of this charge, FDA is working with the pharmaceutical industry and consumer stakeholders to develop REMS for certain classes of medication, including opioid medications. If you are a person with pain, a caregiver or health care professional who treats pain, you are a stakeholder who can play a role in the development of this policy.